By implementing the MDClone platform, non-technical users can quickly ask important questions and find answers, dramatically shortening timelines for quality improvement, innovation, and grass roots clinical research. The initial collaboration with MDClone will center around suicide prevention, chronic disease management, precision medicine, health equity, and COVID-19. For example, practitioners can tackle issues like suicide by identifying leading indicators and proactively intervening with patients most at risk.
Veterans’ privacy and health information will be protected through the use of synthetic data, a technology from MDClone that surpasses traditional de-identification methods, the company said. MDClone was founded in 2016, and works with major health systems, payers, and life science companies in the U.S., Canada, and Israel.